An updated review of a novel method for examining P53 mutations in different forms of cancer
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Navid Shomali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
In the past fifteen years, it has been clear that tumor-associated p53 mutations can cause behaviors distinct from those brought on by a simple loss of p53's tumor-suppressive function in its wild-type form. Many of these mutant p53 proteins develop oncogenic characteristics that allow them to encourage cell survival, invasion, and metastasis. But it is now understood that the immune response is also significantly influenced by the cancer cell's p53 status. The recruitment and activity of myeloid and T cells can be impacted by p53 loss or mutation in malignancies, allowing immune evasion and accelerating cancer growth. Additionally, p53 can work in immune cells, which can have various effects that either hinder or assist the growth of tumors. In this review article, we examined different mutations of P53 in some significant cancers, such as liver, colorectal, and prostate, and reviewed some new therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of History of Medicine, School of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Zitieren
APA
Shomali, N., Kamrani, A., Nasiri, H., Heris, J. A., Shahabi, P., Yousefi, M., Mohammadinasab, R., Sadeghvand, S., & Akbari, M. (2023). An updated review of a novel method for examining P53 mutations in different forms of cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154585
Vancouver
Shomali N, Kamrani A, Nasiri H, Heris JA, Shahabi P, Yousefi M, et al. An updated review of a novel method for examining P53 mutations in different forms of cancer. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154585
BibTeX
@article{Shomali2023,
author = {Shomali, Navid and Kamrani, Amin and Nasiri, Hadi and Heris, Javad Ahmadian and Shahabi, Parviz and Yousefi, Mehdi and Mohammadinasab, Reza and Sadeghvand, Shahram and Akbari, Morteza},
title = {An updated review of a novel method for examining P53 mutations in different forms of cancer},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154585}
}
EUVIMED